Logos Global Management’s Avidity Biosciences RNAM Stock Holding History

Logos Global Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500,000	Closed	-$36.1M	–	83
2025 Q4	$36.1M	Sell	500,000 -100,000	-17%	-$6.46M	2.18%	14
2025 Q3	$26.1M	Sell	600,000 -350,000	-37%	-$14.1M	2.34%	18
2025 Q2	$27M	Buy	950,000 +600,000	+171%	+$17.9M	2.99%	7
2025 Q1	$10.3M	Buy	+350,000	New	+$10.9M	1.84%	20
2024 Q1	–	Sell	-775,000	Closed	-$7.01M	–	67
2023 Q4	$7.01M	Buy	+775,000	New	+$5.18M	0.65%	34
2021 Q1	–	Sell	-671,454	Closed	-$17.1M	–	70
2020 Q4	$17.1M	Sell	671,454 -50,000	-7%	-$1.46M	1.47%	15
2020 Q3	$20.3M	Sell	721,454 -205,000	-22%	-$5.92M	2.6%	11
2020 Q2	$25.6M	Buy	+926,454	New	+$26.7M	5.11%	4

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Logos Global Management's RNAM Position: Q1 2026 in Review

Logos Global Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 500,000 shares — an estimated $36.1M sold.

Logos Global Management first reported a position in RNAM in Q2 2020 and held it in 8 quarters. The position peaked at $36.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Logos Global Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Logos Global Management sold 500,000 Avidity Biosciences shares in Q1 2026, an estimated $36.1M.
Logos Global Management first reported a position in Avidity Biosciences in Q2 2020 and held it in 8 quarters.
Logos Global Management's Avidity Biosciences position peaked at $36.1M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.